VYNE Therapeutics Inc. (VYNE) Earnings Signals & AI Vibe Check
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for VYNE Therapeutics Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, VYNE Therapeutics Inc.'s filing signal
turned negative.
earningsVibe SuperAnalyst™ Verdict:
TURNED NEGATIVE
Signal Performance — Stock Price Since Filing
30-Day Change
-2.00%
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Turned Negative
GEMINI
Turned Negative
CLAUDE
Turned Negative
CHATGPT
Turned Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does VYNE Therapeutics Inc. actually do?
Answer:
VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing differentiated therapies for inflammatory and immune-mediated conditions. The company holds exclusive worldwide rights to research, develop, and commercialize small molecule bromodomain and extra-terminal domain (BET) inhibitors, licensed from Tay Therapeutics Ltd. VYNE's development pipeline includes repibresib, a topical pan-BD BET inhibitor, and VYN202, an oral BD2-selective BET inhibitor. In August 2025, the company initiated a strategic review, leading to a December 2025 merger agreement with Yarrow Biosciences, Inc., which is expected to shift the company's primary focus to Yarrow's clinical-stage TSHR antibody, YB-101, for Graves' disease.
Question:
What are VYNE Therapeutics Inc.'s revenue drivers?
Answer:
Historically, revenue has been generated from development and license agreements, including royalty payments from the sale of Finacea foam. Following the sale of its MST Franchise, the company's primary focus is on pipeline development rather than current product sales.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required